Citadel Advisors
GI

Citadel Advisors’s EndoChoice Holdings, Inc. GI Stock Holding History

Citadel Advisors’s Portfolio GI Stock Details GI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-14,627
Closed -$76K – 7846
2016
Q1 		$76K Sell
14,627
-6,575
-31% -$36.1K ﹤0.01% 6139
2015
Q4 		$177K Buy
+21,202
New +$204K ﹤0.01% 5964

Other funds holding GI

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's GI Position: Q2 2016 in Review

Citadel Advisors sold out of EndoChoice Holdings, Inc. (GI) in Q2 2016, closing a stake of 14,627 shares — an estimated $76K sold.

Citadel Advisors first reported a position in GI in Q4 2015 and held it in 2 quarters. The position peaked at $177K in Q4 2015. 46 funds tracked by Wall St. Rank hold GI as of Q2 2016.

  • Citadel Advisors reported no remaining EndoChoice Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Citadel Advisors sold 14,627 EndoChoice Holdings, Inc. shares in Q2 2016, an estimated $76K.
  • Citadel Advisors first reported a position in EndoChoice Holdings, Inc. in Q4 2015 and held it in 2 quarters.
  • Citadel Advisors's EndoChoice Holdings, Inc. position peaked at $177K in Q4 2015.
  • 46 funds tracked by Wall St. Rank held EndoChoice Holdings, Inc. as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.